Children deserve simple, short, safe, and effective treatment for rifampicin-resistant tuberculosis

Lancet Infect Dis. 2023 Jul;23(7):778-780. doi: 10.1016/S1473-3099(23)00349-3. Epub 2023 May 25.
No abstract available

MeSH terms

  • Antibiotics, Antitubercular* / pharmacology
  • Antibiotics, Antitubercular* / therapeutic use
  • Antitubercular Agents / therapeutic use
  • Child
  • Drug Resistance, Bacterial
  • Humans
  • Mycobacterium tuberculosis*
  • Rifampin / therapeutic use
  • Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

  • Rifampin
  • Antitubercular Agents
  • Antibiotics, Antitubercular